CELLECTAR BIOSCIENCES INC (CLRB) Stock Balance Sheet
NASDAQ:CLRB - US15117F8077 - Common Stock
5.06 USD
+0.08 (+1.61%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.04M | 23.29M | 9.56M | 19.87M | 35.70M | |||
| Other Current Assets | 1.58M | 961.70K | 888.20K | 660.00K | 870.00K | |||
| Total Current Assets | 12.62M | 24.25M | 10.45M | 20.53M | 36.57M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.05M | 1.19M | 1.59M | 980.00K | 550.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 29.80K | 29.80K | 29.80K | 80.00K | 80.00K | |||
| Total Non-Current Assets | 1.08M | 1.22M | 1.62M | 1.06M | 630.00K | |||
| TOTAL ASSETS | 13.70M | 25.47M | 12.08M | 21.59M | 37.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 92.00K | 2.23M | 2.37M | 1.33M | 690.00K | |||
| Accounts Payable | 4.68M | 5.44M | 6.87M | 4.20M | 3.30M | |||
| Other Current Liabilities | 1.10M | 1.72M | 3.70M | N/A | N/A | |||
| Total Current Liabilities | 5.87M | 9.39M | 12.94M | 5.53M | 3.99M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 361.50K | 409.60K | 494.00K | 550.00K | 170.00K | |||
| Total Non-Current Liabilities | 361.50K | 409.50K | 494.00K | 550.00K | 170.00K | |||
| TOTAL LIABILITIES | 6.23M | 9.80M | 13.43M | 6.08M | 4.16M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -259.39M | -247.34M | -217.48M | -179.50M | -150.90M | |||
| Additional Paid In Capital | 264.96M | 261.12M | 210.07M | 193.62M | 182.56M | |||
| Common Shares | 1.90M | 1.90M | 6.06M | 1.38M | 1.38M | |||
| Shares Outstanding | 1.81M | 1.54M | 691.40K | 312.80K | 203.70K | |||
| Tangible Book Value per Share | 3.07 | 8.97 | -10.73 | 45.17 | 155.51 | |||
| Total Shareholders' Equity | 7.47M | 15.68M | -1.36M | 15.51M | 33.05M | |||
| TOTAL LIABILITIES AND EQUITY | 13.70M | 25.47M | 12.08M | 21.59M | 37.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.15 | 2.58 | 0.81 | 3.71 | 9.17 | |||
| Return On Assets (ROA) | -212.28% | -175.01% | -354.19% | -132.47% | -64.84% | |||
| Return On Equity (ROE) | -389.34% | -284.38% | N/A | -184.40% | -72.98% | |||
All data in USD , ROIC based on taxRate of 0.21